Usability and feasibility of PreventS-MD web app for stroke prevention

Author:

Feigin Valery L1ORCID,Krishnamurthi Rita1,Medvedev Oleg2,Merkin Alexander1,Nair Balakrishnan1,Kravchenko Michael3ORCID,Jalili-Moghaddam Shabnam1,Barker-Collo Suzanne4ORCID,Ratnasabapathy Yogini5,Skinner Luke5,Owolabi Mayowa6ORCID,Norrving Bo7,Sachdev Perminder S89ORCID,Arroll Bruce10,Brainin Michael11ORCID,Thrift Amanda12ORCID,Hankey Graeme J1314ORCID,Abd-Allah Foad15,Akinyemi Rufus16,Azarpazhooh Reza17,Bhatia Anjali18,Bath Philip M19,Brayne Carol20,Budincevic Hrvoje2122,Child Nicholas5,Chwojnicki Kamil23,Correia Manuel24,Davis Alan25,Devlin Gerry2627,Demarin Vida28,Dhamija Rajinder K29,Ding Ding30,Dokova Klara31,Dudley Makarena4,Dyer Jesse18,Edmonds Misty32,Ely Marcela33,Farhoudi Mehdi34,Feigin Svetlana35,Fornolles Caroline36,Firzah Abdul Aziz Aznida37,Gabriel Denis38,Gall Seana39,Gil Artyom4041,Gnedovskaya Elena3,George Ann18,Haršány Michal33,Harwood Matire42,Hillis Argye43,Hou Zeng-Guang44,Hwang Kevin45,Ibrahim Norlinah37,Ka’ai Tania46,Kalra Nidhi47,Katzenellenbogen Judith48,Zhe Kang Law37,Kar Arindam49,Karaszewski Bartosz5051,Kazin Vitalij52,Kivipelto Miia53,Kamenova Saltanat54,Kondybaeva Aida54,Lavados Pablo55,Lee Tsong-Hai56,Liu Liping57,Mahawish Karim49,Maluchnik Michal58,Martins Sheila5960,Mateen Farrah61,Mavaddat Nahal48,Mohan Mehndiratta Man62,Mikulik Robert33,Oliver Angela5,Özturk Serefnur63,Patel Nikhil36,Piradov Michael3,Prakash Binita5,Purvis Tara64,Reips Ulf-Dietrich65,Roos Kev32,Rosand Jonathan666768,Sahathevan Ramesh69,Sekaran Lakshmanan36,Shamalov Nikolay70,Anne De Silva Deidre71,Singh Vinod5,Solomon Alina53,Srivastava Padma72,Suwanwela Nijasri C7374,Taylor Denise75,Truelsen Thomas76,Venketasubramanian Narayanaswamy77,Volevach Ekaterina33,Volný Ondřej78,Wan Joyce5,Withanapathirana Katila79,Welte Tamara8081,Wiebers David82,Winkler Andrea S8384,Wijeratne Tissa85,Wu Teddy86,Asyraf Wan Zaidi Wan37

Affiliation:

1. National Institute for Stroke and Applied Neurosciences, School of Clinical Sciences, Auckland University of Technology, Auckland, New Zealand

2. School of Psychology, University of Waikato, Hamilton, New Zealand

3. Research Center of Neurology, Moscow, Russia

4. School of Psychology, The University of Auckland, Auckland, New Zealand

5. Te Whatu Ora—Health New Zealand, Waitematā, Auckland, New Zealand

6. Center for Genomic and Precision Medicine, College of Medicine, University of Ibadan, Ibadan, Nigeria

7. Section of Neurology, Lund University, Skåne University Hospital, Lund, Sweden

8. Centre for Healthy Brain Ageing (CHeBA), School of Psychiatry, University of New South Wales (UNSW), Sydney, NSW, Australia

9. Neuropsychiatric Institute, The Prince of Wales Hospital, Sydney, NSW, Australia

10. Department of General Practice and Primary Health Care, The University of Auckland, Auckland, New Zealand

11. Danube University Krems, Krems an der Donau, Austria

12. Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Melbourne, VIC, Australia

13. Medical School, Faculty of Health and Medical Sciences, The University of Western Australia, Perth, WA, Australia

14. Perron Institute for Neurological and Translational Science, Perth, WA, Australia

15. Department of Neurology, Kasr AlAiny School of Medicine, Cairo University, Cairo, Egypt

16. Neuroscience and Aging Research Unit, Institute for Advanced Medical Research and Training, College of Medicine, University of Ibadan, Ibadan, Nigeria

17. Department of Clinical Neurological Sciences and Epidemiology, University of Western Ontario, London, ON, Canada

18. National Institute for Stroke and Applied Neurosciences, Auckland University of Technology, Auckland, New Zealand

19. Stroke Trials Unit, Mental Health & Clinical Neuroscience, University of Nottingham, Nottingham, UK

20. Institute of Public Health, University of Cambridge, Cambridge, UK

21. Department of Neurology, Sveti Duh University Hospital, Zagreb, Croatia

22. Department of Neurology and Neurosurgery, Faculty of Medicine, J.J. Strossmayer University of Osijek, Osijek, Croatia

23. Division of Anaesthesiology & Intensive Care, Faculty of Medicine, Medical University of Gdańsk, Gdańsk, Poland

24. Department of Neurology, Centro Hospitalar Universitário do Porto, Instituto de Ciências Biomédicas Abel Salazar, University of Porto, Porto, Portugal

25. Te Whatu Ora—Health New Zealand, Te Tai Tokerau Northland, Whangārei, New Zealand

26. Te Whatu Ora—Health New Zealand, Tairāwhiti, New Zealand

27. New Zealand Heart Foundation, Auckland, New Zealand

28. Department of Medical Sciences of the Croatian Academy of Sciences and Arts, Zagreb, Croatia

29. Institute of Human Behavior and Allied Sciences, New Delhi, India

30. Institute of Neurology, Fudan University Huashan Hospital, Shanghai, China

31. Faculty of Public Health, Medical University “Prof. Dr. Paraskev Stoyanov”, Varna, Bulgaria

32. Iwi United Engagement Limited, Auckland, New Zealand

33. International Clinical Research Center, St. Anne’s University Hospital in Brno, Brno, Czech Republic

34. Neuroscience Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

35. All Life Institute, Washington, DC, USA

36. Luton and Dunstable University Hospital, Bedfordshire, UK

37. Universiti Kebangsaan Malaysia Medical Center, Kuala Lumpur, Malaysia

38. Department of Neurology, Hospital de Santo António, Centro Hospitalar Universitário do Porto, Porto, Portugal

39. Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia

40. Division of Country Health Programs, WHO European Office for the Prevention and Control of Noncommunicable Diseases, Moscow, Russia

41. WHO Country Office, Astana, Kazakhstan

42. Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand

43. Johns Hopkins University, Baltimore, MD, USA

44. State Key Lab of Management and Control for Complex Systems, Institute of Automation, Chinese Academy of Sciences, Beijing, China

45. McGovern Medical School at UTHealth Houston, Houston, TX, USA

46. Te Ipukarea Research Institute, Faculty of Design and Creative Technologies, Auckland University of Technology, Auckland, New Zealand

47. Banarsidas Chandiwala Institute of Physiotherapy GGSIP University, New Delhi, India

48. The University of Western Australia, Perth, WA, Australia

49. Te Whatu Ora—Health New Zealand, Counties Manukau, Auckland, New Zealand

50. Department of Adult Neurology, Faculty of Medicine, Medical University of Gdansk, Gdańsk, Poland

51. Brain Diseases Center, Medical University of Gdańsk, Gdańsk, Poland

52. CPPN, Venlo University, Venlo, The Netherlands

53. Karolinska Institutet, Solna, Sweden

54. Higher School of Medicine, Al-Farabi Kazakh National University, Almaty, Kazakhstan

55. Department of Neurology & Psychiatry, Research & Clinical Trials Unit, Clínica Alemana, Universidad del Desarrollo, Santiago, Chile

56. Stroke Center and Department of Neurology, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan

57. Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China

58. Ministry of Health of the Republic of Poland, Warsaw, Poland

59. Universidade Federal do Rio Grande do Sul, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil

60. Hospital Moinhos de Vento, Porto Alegre, Brazil

61. Department of Neurology, Massachusetts General Hospital, Boston, MA, USA

62. Center for Neurosciences, BLK-MAX Super Speciality Hospital, New Delhi, India

63. Department of Neurology, Faculty of Medicine, Selçuk University, Konya, Turkey

64. Stroke and Aging Research Group (STAR), School of Clinical Sciences at Monash Health, Monash University, Melbourne, VIC, Australia

65. Research Methods, Assessment & Science, Department of Psychology, University of Konstanz, Konstanz, Germany

66. Henry and Allison McCance Center for Brain Health, Massachusetts General Hospital, Boston, MA, USA

67. Harvard Medical School, Boston, MA, USA

68. Broad Institute, Cambridge, MA, USA

69. Ballarat Health Services, Ballarat, VIC, Australia

70. Federal Center of Brain Research and Neurotechnologies of the Federal Medical Biological Agency, Moscow, Russia

71. Department of Neurology, The National Neuroscience Institute, Singapore, Singapore

72. Department of Neurology, Neurosciences Center, AIIMS, New Delhi, India

73. Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand

74. Chulalongkorn Comprehensive Stroke Center, King Chulalongkorn Memorial Hospital, Bangkok, Thailand

75. Health and Rehabilitation Research Institute, Auckland University of Technology, Auckland, New Zealand

76. Department of Neurology, University of Copenhagen, Rigshospitalet, Copenhagen, Denmark

77. Raffles Neuroscience Center, Raffles Hospital, Singapore, Singapore

78. University Hospital Ostrava, Ostrava, Czech Republic

79. Three Kings Accident and Medical Clinic, Auckland, New Zealand

80. Department of Neurology, Center for Global Health, Technical University of Munich, Munich, Germany

81. Center for Global Health, Institute of Health and Society, University of Oslo, Oslo, Norway

82. Divisions of Cerebrovascular Diseases and Epidemiology, Departments of Neurology and Health Sciences Research, Mayo Clinic and Mayo Foundation, Rochester, MN, USA

83. Department of Neurology, University of Erlangen-Nuremberg, Erlangen, Germany

84. Department of Neurology, Center for Global Health, Technical University of Erlangen, Erlangen, Germany

85. Department of Neurology, Stroke Services, Department of Medicine, Sunshine Hospital, Western Health, Melbourne Medical School, St. Albans, VIC, Australia

86. Department of Neurology, Christchurch Hospital, Christchurch, New Zealand

Abstract

Background: Most strokes and cardiovascular diseases (CVDs) are potentially preventable if their risk factors are identified and well controlled. Digital platforms, such as the PreventS-MD web app (PreventS-MD) may aid health care professionals (HCPs) in assessing and managing risk factors and promoting lifestyle changes for their patients. Methods: This is a mixed-methods cross-sectional two-phase survey using a largely positivist (quantitative and qualitative) framework. During Phase 1, a prototype of PreventS-MD was tested internationally by 59 of 69 consenting HCPs of different backgrounds, age, sex, working experience, and specialties using hypothetical data. Collected comments/suggestions from the study HCPs in Phase 1 were reviewed and implemented. In Phase 2, a near-final version of PreventS-MD was developed and tested by 58 of 72 consenting HCPs using both hypothetical and real patient (n = 10) data. Qualitative semi-structured interviews with real patients (n = 10) were conducted, and 1 month adherence to the preventive recommendations was assessed by self-reporting. The four System Usability Scale (SUS) groups of scores (0–50 unacceptable; 51–68 poor; 68–80.3 good; >80.3 excellent) were used to determine usability of PreventS-MD. Findings: Ninety-nine HCPs from 27 countries (45% from low- to middle-income countries) participated in the study, and out of them, 10 HCPs were involved in the development of PreventS before the study, and therefore were not involved in the survey. Of the remaining 89 HCPs, 69 consented to the first phase of the survey, and 59 of them completed the first phase of the survey (response rate 86%), and 58 completed the second phase of the survey (response rate 84%). The SUS scores supported good usability of the prototype (mean score = 80.2; 95% CI [77.0–84.0]) and excellent usability of the final version of PreventS-MD (mean score = 81.7; 95% CI [79.1–84.3]) in the field. Scores were not affected by the age, sex, working experience, or specialty of the HCPs. One-month follow-up of the patients confirmed the high level of satisfaction/acceptability of PreventS-MD and (100%) adherence to the recommendations. Interpretation: The PreventS-MD web app has a high level of usability, feasibility, and satisfaction by HCPs and individuals at risk of stroke/CVD. Individuals at risk of stroke/CVD demonstrated a high level of confidence and motivation in following and adhering to preventive recommendations generated by PreventS-MD.

Publisher

SAGE Publications

Subject

Neurology,Neurology (clinical)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3